Pancreatic Cancer Clinical Trials in Pennsylvania

Showing 141-143 of 143 trials

Vapreotide in Treating Patients Undergoing Elective Pancreatic Resection

NCT00014651

RATIONALE: Drugs such as vapreotide may prevent complications following pancreatic resection. It is not yet known if vapreotide is more effective than no further therapy in preventing side effects of pancreatic resection. PURPOSE: This randomized phase III trial is studying vapreotide to see how well it works compared to a placebo in preventing complications in patients undergoing surgery for pancreatic cancer.

Pancreatic CancerPerioperative/Postoperative Complications

Mayo ClinicStarted Mar 2001

Birmingham, Alabama, United States • Tampa, Florida, United States • Chicago, Illinois, United States +15 more locations

COMPLETEDPhase 397 miles

Study of the Efficacy and Safety of Glufosfamide Compared With Best Supportive Care in Metastatic Pancreatic Cancer

NCT00099294

The primary objectives of the study is to evaluate the effectiveness and safety of glufosfamide in subjects with pancreatic cancer who have been previously treated with gemcitabine as measured by overall survival compared with best supportive care.

Pancreatic Cancer

Threshold Pharmaceuticals300 participantsStarted Sep 2004

Los Angeles, California, United States • Los Angeles, California, United States • Denver, Colorado, United States +108 more locations

Vapreotide in Treating Patients Undergoing Elective Pancreatic Resection

Study of the Efficacy and Safety of Glufosfamide Compared With Best Supportive Care in Metastatic Pancreatic Cancer

Pancreatic Cancer Trials in Other Cities

A Registry of Patients Undergoing Cellvizio Endomicroscopy and Endoscopic Retrograde Cholangiopancreatography(ERCP) Imaging Procedures for Diagnosing Pancreatic and Bile Duct Cancers

Other Conditions in Pennsylvania